Ancell Corporation

What Ancell Corporation does

Ancell Corporation is a US-based immunology research reagent manufacturer founded in 1992 and headquartered in Bayport, Minnesota. The company develops and produces monoclonal antibodies (anti-human and anti-mouse), recombinant fusion proteins in proprietary muIg and muCD8 formats, and second-step detection reagents for flow cytometry, immunoassay, immunohistochemistry, Western blot, and immunoprecipitation applications. Its catalog spans immune checkpoint markers, TNF superfamily members, cytokines, tetraspanins (CD9/CD63/CD81), and isotype controls, with products available in multiple conjugated formats (Purified, Biotin, FITC, R-PE, APC, HRP). All products are labeled for research use only — not for diagnostic or therapeutic purposes.

The company's business model is direct unit sales of catalog research reagents at price points ranging from approximately $200 to $745 per SKU, paid transactionally with no subscription or licensing model. US customers order directly through ancell.com with toll-free phone support, while international customers are served through regional distributors. The primary customer base is academic and research institutions conducting immunology and biomedical research, with a secondary segment in pharmaceutical and biotechnology companies using the reagents for drug discovery, target validation, and biomarker work. The company is privately held with no disclosed institutional investors, operates from a single US facility, and reports 11-50 employees.

Ancell maintains a content marketing presence via a 'Hot Topics' blog that surfaces peer-reviewed publications (through 2025-2026) citing Ancell reagents across cancer immunotherapy, CAR-T engineering, extracellular vesicle research, and humanized mouse model studies — a strategy aimed at reinforcing product validation and discoverability among research buyers.

Name

Ancell Corporation

Legal name

Ancell Corporation

Website

https://ancell.com

Company type

Private

Founded year

1992

Operating status

Operating

Headcount range

11–50 employees

Short description

Ancell Corporation is a privately held US manufacturer of monoclonal antibodies and recombinant fusion proteins for immunology research, serving academic laboratories and pharmaceutical companies via direct US sales and international distributors.

Ownership category

akta.pro rank

Product category

Life Sciences Research Reagents

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Pharmaceutical and Medicine Manufacturing (3254)

SIC

In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)

akta.pro secondary industries

Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering) (HLAAAIAB), Bioprocess Consumables & Reagents (resins, membranes, media components, buffers) (HLAAAJAI)

Keywords

• Monoclonal antibodies
• Recombinant proteins
• Flow cytometry reagents
• Immunology research tools
• Immune checkpoint antibodies

Headquarters

HQ city

Bayport

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Operations, Technology or R&D, Infrastructure

Revenue model

1. Research Antibodies and Proteins Sales: Direct sales of immunology research products including monoclonal antibodies, recombinant proteins, and second-step reagents to research institutions, universities, and pharmaceutical companies worldwide

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels2 records

Core offering

Ancell Corporation manufactures and distributes immunology research reagents, primarily monoclonal antibodies and recombinant fusion proteins, for use in flow cytometry, immunoassays, immunohistochemistry, Western blot, and immunoprecipitation. Products are sold in multiple conjugate formats (Purified, Biotin, FITC, R-PE, APC, HRP) directly to US customers via the company's website and internationally through regional distributors. All products are intended for scientific research use only and are not for diagnostic or therapeutic use.

Product overview

Ancell Corporation is an immunology research products company founded in 1992 that develops and manufactures high-quality monoclonal antibodies and recombinant proteins for scientific research. The product portfolio includes anti-human and anti-mouse antibodies across multiple product categories (Anti-Human Antibodies, Anti-Mouse Antibodies, Cytokine Related, Immune Checkpoint, Isotype Controls, Progenitor/Stem Cell, Recombinant Proteins, Second-Step Reagents, and TNF Superfamily), as well as tetraspanin antibodies. The Recombinant Proteins line features fusion proteins including muIg and muCD8 conjugates (CD40-muIg, CD134(OX40)-muIg, CD252(OX40L)-muCD8, CD257(BAFF)-muCD8, CD268(BAFFR)-muIg, CD95(Fas)-huIg, TIGIT-muIg). Products are available in multiple conjugated forms (Purified, Biotin, FITC, R-PE, APC, HRP) for applications including flow cytometry, immunohistochemistry, enzyme immunoassay, Western blot, and immunoprecipitation. All Ancell products are intended for scientific research use only and are not for diagnostic or therapeutic use.

Differentiator

Problem solved

Functional benefit

Products and services

• Anti-Human Antibodies Monoclonal antibodies targeting human cell surface antigens for flow cytometry, immunohistochemistry, and other immunological assays. Intended for scientific research use in academic, government, and pharmaceutical research laboratories.
• Anti-Mouse Antibodies Monoclonal antibodies targeting mouse cell surface antigens for research applications, including flow cytometry and immunoassays in murine model systems. Intended for scientific research use.
• Cytokine Related Products

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators2 records

Recent moves4 records

Expansion highlights3 records

Direct peers

• BioLegend: BioLegend is a leading manufacturer of antibodies and reagents for immunology and flow cytometry research, directly competing with Ancell's core product portfolio of monoclonal antibodies and recombinant proteins for academic and pharmaceutical researchers.
• Cell Signaling Technology: Cell Signaling Technology produces high-quality antibodies for cell signaling and immunology research, directly overlapping with Ancell's monoclonal antibody offerings for immune checkpoint, TNF superfamily, and signaling pathway research.
• Miltenyi Biotec: Miltenyi Biotec produces antibodies, cell separation reagents, and immunology research tools, competing with Ancell in flow cytometry antibodies and recombinant protein offerings for immunology research applications.
• Santa Cruz Biotechnology: Santa Cruz Biotechnology offers an extensive catalog of research antibodies across multiple research areas including immunology, providing direct competition to Ancell's monoclonal antibody products for academic researchers.
• Abcam: Abcam is a major research antibody supplier serving academic and pharmaceutical markets with a catalog similar in scope to Ancell's, including antibodies for immunology, cell biology, and cancer research applications.
• STEMCELL Technologies: STEMCELL Technologies manufactures cell culture media, antibodies, and reagents for stem cell and immunology research, with overlapping products in progenitor/stem cell and immune cell characterization markets where Ancell competes.
• Bio-Techne (R&D Systems): Bio-Techne's R&D Systems brand manufactures antibodies, recombinant proteins, and immunoassay reagents for immunology and cell biology research, directly comparable to Ancell's product portfolio and customer segments.

Emerging players

• Tonbo Biosciences: Tonbo Biosciences specializes in flow cytometry reagents and antibodies for immunology research, representing a smaller-scale competitor with overlapping product categories targeting similar academic and research customers.

Broad incumbents

• BD Biosciences: BD Biosciences is a major supplier of flow cytometry instruments and antibodies for immunology research, representing a larger incumbent that competes with Ancell's antibody products used in flow cytometry applications.
• Thermo Fisher Scientific: Thermo Fisher Scientific offers an extensive portfolio of life science reagents including antibodies through its Invitrogen and Thermo Scientific brands, competing broadly with Ancell across immunology research applications.

Market position

Strengths1 record

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/profile.php

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ancell Corporation